Ava Nasrolahi

532 total citations
27 papers, 373 citations indexed

About

Ava Nasrolahi is a scholar working on Molecular Biology, Cancer Research and Cellular and Molecular Neuroscience. According to data from OpenAlex, Ava Nasrolahi has authored 27 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Cancer Research and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Ava Nasrolahi's work include Cancer-related molecular mechanisms research (10 papers), Circular RNAs in diseases (7 papers) and MicroRNA in disease regulation (6 papers). Ava Nasrolahi is often cited by papers focused on Cancer-related molecular mechanisms research (10 papers), Circular RNAs in diseases (7 papers) and MicroRNA in disease regulation (6 papers). Ava Nasrolahi collaborates with scholars based in Iran, United States and Poland. Ava Nasrolahi's co-authors include Maryam Farzaneh, Javad Mahmoudi, Seyed Esmaeil Khoshnam, Mehdi Farhoudi, Saeed Sadigh‐Eteghad, Shirin Azizidoost, Fatemeh Safari, Shahab Ghaderi, Masome Rashno and Habib Zarredar and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cellular Signalling and Molecular Neurobiology.

In The Last Decade

Ava Nasrolahi

26 papers receiving 365 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ava Nasrolahi Iran 12 163 71 69 63 54 27 373
Udhaya Kumari Singapore 6 191 1.2× 56 0.8× 57 0.8× 95 1.5× 55 1.0× 8 350
Kyoungjoo Cho South Korea 10 149 0.9× 47 0.7× 90 1.3× 27 0.4× 45 0.8× 25 340
Qiaoying Huang China 12 228 1.4× 35 0.5× 131 1.9× 75 1.2× 27 0.5× 28 423
Angelo Serani Italy 10 219 1.3× 95 1.3× 38 0.6× 39 0.6× 29 0.5× 18 355
Alicia Gates United States 9 189 1.2× 45 0.6× 85 1.2× 63 1.0× 33 0.6× 10 381
Susana Masiá Spain 4 343 2.1× 45 0.6× 101 1.5× 69 1.1× 68 1.3× 5 486
Riyun Yang China 10 163 1.0× 36 0.5× 66 1.0× 19 0.3× 89 1.6× 17 323
Luan Cen China 10 156 1.0× 50 0.7× 85 1.2× 126 2.0× 45 0.8× 16 368
Xiuquan Wu China 12 184 1.1× 34 0.5× 44 0.6× 67 1.1× 31 0.6× 28 386

Countries citing papers authored by Ava Nasrolahi

Since Specialization
Citations

This map shows the geographic impact of Ava Nasrolahi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ava Nasrolahi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ava Nasrolahi more than expected).

Fields of papers citing papers by Ava Nasrolahi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ava Nasrolahi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ava Nasrolahi. The network helps show where Ava Nasrolahi may publish in the future.

Co-authorship network of co-authors of Ava Nasrolahi

This figure shows the co-authorship network connecting the top 25 collaborators of Ava Nasrolahi. A scholar is included among the top collaborators of Ava Nasrolahi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ava Nasrolahi. Ava Nasrolahi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Azizidoost, Shirin, et al.. (2024). The Role of Long Non-Coding RNAs in the Pathogenesis of EssentialHypertension. Current Signal Transduction Therapy. 19(2). 1 indexed citations
2.
Al-Dahmoshi, Hussein O.M., et al.. (2024). Prevalence of plasmid-mediated quinolone resistance genes and biofilm formation in different species of quinolone-resistant clinical Shigella isolates: a cross-sectional study. European journal of medical research. 29(1). 419–419. 4 indexed citations
3.
Nasrolahi, Ava, et al.. (2023). Potential roles of lncRNA MALAT1-miRNA interactions in ocular diseases. Journal of Cell Communication and Signaling. 17(4). 1203–1217. 6 indexed citations
4.
Nasrolahi, Ava, et al.. (2023). Stem Cell Therapy for the Treatment of Parkinson's Disease: What PromiseDoes it Hold?. Current Stem Cell Research & Therapy. 19(2). 185–199. 3 indexed citations
5.
Azizidoost, Shirin, et al.. (2023). Signaling pathways governing the behaviors of leukemia stem cells. Genes & Diseases. 11(2). 830–846. 11 indexed citations
6.
Farzaneh, Maryam, Shirin Azizidoost, Ava Nasrolahi, et al.. (2023). The Mechanisms of Long Non-coding RNA-XIST in Ischemic Stroke: Insights into Functional Roles and Therapeutic Potential. Molecular Neurobiology. 61(5). 2745–2753. 3 indexed citations
7.
Azizidoost, Shirin, Ava Nasrolahi, Paweł Antosik, et al.. (2023). Potential roles of endothelial cells-related non-coding RNAs in cardiovascular diseases. Pathology - Research and Practice. 242. 154330–154330. 2 indexed citations
8.
Bayati, Vahid, et al.. (2023). Evaluation of the effects of ethanol and mitomycin on survival of rat limbal stem cells: an in vitro study. International Ophthalmology. 43(7). 2503–2512. 1 indexed citations
9.
Ghaedrahmati, Farhoodeh, Ava Nasrolahi, Sajad Najafi, et al.. (2023). Circular RNAs-mediated angiogenesis in human cancers. Clinical & Translational Oncology. 25(11). 3101–3121. 7 indexed citations
10.
Nasrolahi, Ava, et al.. (2023). Mitochondrial Dysfunction and Parkinson’s Disease: Pathogenesis and Therapeutic Strategies. Neurochemical Research. 48(8). 2285–2308. 69 indexed citations
11.
Farzaneh, Maryam, Ava Nasrolahi, Farhoodeh Ghaedrahmati, et al.. (2023). Potential roles of lncRNA-XIST/miRNAs/mRNAs in human cancer cells. Clinical & Translational Oncology. 25(7). 2015–2042. 12 indexed citations
12.
Nasrolahi, Ava, et al.. (2022). Cerebral dopamine neurotrophic factor increases proliferation, Migration and differentiation of subventricular zone neuroblasts in photothrombotic stroke model of mouse. Journal of Stroke and Cerebrovascular Diseases. 31(11). 106725–106725. 3 indexed citations
13.
Nasrolahi, Ava, Shirin Azizidoost, Sajad Najafi, et al.. (2022). Long non-coding RNAs involved in retinoblastoma. Journal of Cancer Research and Clinical Oncology. 149(1). 401–421. 11 indexed citations
14.
Azizidoost, Shirin, Ava Nasrolahi, Farhoodeh Ghaedrahmati, et al.. (2022). The pathogenic roles of lncRNA-Taurine upregulated 1 (TUG1) in colorectal cancer. Cancer Cell International. 22(1). 335–335. 12 indexed citations
15.
Farzaneh, Maryam, et al.. (2022). The stem cell-specific long non-coding RNAs in leukemia. Clinical & Translational Oncology. 25(2). 345–351. 5 indexed citations
16.
Nasrolahi, Ava, Shirin Azizidoost, Sajad Najafi, et al.. (2022). Signaling pathways governing glioma cancer stem cells behavior. Cellular Signalling. 101. 110493–110493. 30 indexed citations
17.
Nasrolahi, Ava, et al.. (2021). Therapeutic potential of neurotrophic factors in Alzheimer’s Disease. Molecular Biology Reports. 49(3). 2345–2357. 23 indexed citations
18.
Nasrolahi, Ava, et al.. (2020). Do Genetic Factors Predispose People to COVID-19: A Review Article. Current Molecular Medicine. 21(6). 457–461. 1 indexed citations
19.
Nasrolahi, Ava, Javad Mahmoudi, Mohammad Karimipour, et al.. (2019). Effect of cerebral dopamine neurotrophic factor on endogenous neural progenitor cell migration in a rat model of Parkinson's disease. PubMed. 18. 139–153. 16 indexed citations
20.
Nasrolahi, Ava, Javad Mahmoudi, Abolfazl Akbarzadeh, et al.. (2018). Neurotrophic factors hold promise for the future of Parkinson’s disease treatment: is there a light at the end of the tunnel?. Reviews in the Neurosciences. 29(5). 475–489. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Udhaya Kumari Breakdown of academic impact, for papers by Kyoungjoo Cho Breakdown of academic impact, for papers by Qiaoying Huang Breakdown of academic impact, for papers by Angelo Serani Breakdown of academic impact, for papers by Alicia Gates Breakdown of academic impact, for papers by Susana Masiá Breakdown of academic impact, for papers by Riyun Yang Breakdown of academic impact, for papers by Luan Cen Breakdown of academic impact, for papers by Xiuquan Wu
Rankless by CCL
2026